Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Public ClinicalTrials.gov record NCT07596901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients With Generalized Myasthenia Gravis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.
Study identification
- NCT ID
- NCT07596901
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 21, 2026
- Primary completion
- Mar 1, 2029
- Completion
- Mar 1, 2029
- Last update posted
- Aug 2, 2026
2026 – 2029
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aurinia Investigational Site | Pasadena | California | 91106 | Recruiting |
| Aurinia Investigational Site | Altamonte Springs | Florida | 32714 | Recruiting |
| Aurinia Investigational Site | Boca Raton | Florida | 33487 | Recruiting |
| Aurinia Investigational Site | Homestead | Florida | 33033 | Recruiting |
| Aurinia Investigational Site | Miami | Florida | 33155 | Recruiting |
| Aurinia Investigational Site | Miami | Florida | 33173 | Recruiting |
| Aurinia Investigational Site | Chicago | Illinois | 60616 | Recruiting |
| Aurinia Investigational Site | O'Fallon | Illinois | 62269 | Recruiting |
| Aurinia Investigational Site | Dearborn | Michigan | 48126 | Recruiting |
| Aurinia Investigational Site | Flint | Michigan | 48507 | Recruiting |
| Aurinia Investigational Site | Houston | Texas | 77027 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07596901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 2, 2026 · Synced Sep 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07596901 live on ClinicalTrials.gov.